|
GCN1L1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.190400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.629510E-02 |
| Normal-vs-Stage2 |
2.365200E-01 |
| Normal-vs-Stage3 |
7.853000E-01 |
| Normal-vs-Stage4 |
8.352400E-01 |
| Stage1-vs-Stage2 |
8.849200E-01 |
| Stage1-vs-Stage3 |
7.156400E-02 |
| Stage1-vs-Stage4 |
4.628400E-01 |
| Stage2-vs-Stage3 |
2.829800E-01 |
| Stage2-vs-Stage4 |
6.187000E-01 |
| Stage3-vs-Stage4 |
7.318000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.855190E-01 |
| Normal-vs-AfricanAmerican |
2.187600E-01 |
| Normal-vs-Asian |
6.459900E-02 |
| Caucasian-vs-AfricanAmerican |
8.706200E-01 |
| Caucasian-vs-Asian |
5.218800E-01 |
| AfricanAmerican-vs-Asian |
4.957000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.245600E-02 |
| Normal-vs-Female |
1.986980E-01 |
| Male-vs-Female |
2.480700E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.482800E-01 |
| Normal-vs-Extreme_Weight |
2.377100E-04 |
| Normal-vs-Obese |
8.773200E-01 |
| Normal-vs-Extreme_Obese |
1.890250E-02 |
| Normal_Weight-vs-Extreme_Weight |
3.435900E-02 |
| Normal_Weight-vs-Obese |
4.417400E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.808200E-01 |
| Extreme_Weight-vs-Obese |
2.260100E-03 |
| Extreme_Weight-vs-Extreme_Obese |
9.723800E-01 |
| Obese-vs-Extreme_Obese |
1.393630E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.364100E-02 |
| Normal-vs-Age(41-60Yrs) |
3.459000E-01 |
| Normal-vs-Age(61-80Yrs) |
6.330400E-02 |
| Normal-vs-Age(81-100Yrs) |
7.197600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.468190E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.304200E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.275800E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.518800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.837640E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.892200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.501900E-02 |
| Normal-VS-Type2 PRCC |
2.105000E-01 |
| Normal-VS-KIRP CIMP |
2.498800E-01 |
| Normal-VS-Unclassified PRCC |
2.347000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
7.504400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.146580E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.401700E-02 |
| Type2 PRCC-VS-KIRP CIMP |
4.077500E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
4.660300E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
4.953200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.738300E-03 |
| Normal-vs-N1 |
2.510200E-01 |
| Normal-vs-N2 |
3.436200E-01 |
| N0-vs-N1 |
1.582270E-02 |
| N0-vs-N2 |
1.868410E-02 |
| N1-vs-N2 |
6.938800E-01 |
|
|
